Stephane Bancel, Chief Executive Officer at Moderna, Inc. (MRNA), sold 150,650 shares at $125.24 ($18.8M) on 2023-05-18, disclosed to the SEC on 2023-05-19.
Scheduled sale ($18.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.22 | 2,333 | $287K | 1.5% |
| 2 | $123.22 | 2,333 | $287K | 1.5% |
| 3 | $124.24 | 9,350 | $1.2M | 6.2% |
| 4 | $125.34 | 11,547 | $1.4M | 7.7% |
| 5 | $125.34 | 11,547 | $1.4M | 7.7% |
| 6 | $126.17 | 16,248 |
| $2.1M |
| 10.9% |
| 7 | $126.17 | 16,248 | $2.1M | 10.9% |
| 8 | $126.86 | 522 | $66K | 0.4% |
| 9 | $126.86 | 522 | $66K | 0.4% |
| 10 | $123.53 | 28,476 | $3.5M | 18.7% |
| 11 | $123.53 | 28,476 | $3.5M | 18.7% |
| 12 | $124.31 | 10,653 | $1.3M | 7.1% |
| 13 | $124.31 | 10,653 | $1.3M | 7.1% |
| 14 | $125.24 | 871 | $109K | 0.6% |
| 15 | $125.24 | 871 | $109K | 0.6% |
| Total | $124.56 avg | 150,650 | $18.8M | 100% |
| Filing → |
| MRNA | SELL | 2024-02-16 | $4.7M | — | Filing → |
| MRNA | SELL | 2023-06-30 | $6.6M | — | Filing → |
| MRNA | SELL | 2023-06-23 | $19.3M | — | Filing → |